Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug 22:10:229-232.
doi: 10.2147/PGPM.S140461. eCollection 2017.

Updating the landscape of direct-to-consumer pharmacogenomic testing

Kelly K Filipski  1 , John D Murphy  1 , Kathy J Helzlsouer  1
Affiliations
Review

Updating the landscape of direct-to-consumer pharmacogenomic testing

Kelly K Filipski et al. Pharmgenomics Pers Med. .

Abstract

Pharmacogenomics has identified important drug-gene interactions that affect the safety and efficacy of medications. Direct-to-consumer genetic testing, when first introduced, included some pharmacogenomic-related genes. The current landscape of pharmacogenomic direct-to-consumer testing is reviewed. Prior published reviews of the literature were updated through February 2017 and a scan of the current availability of direct-to-consumer genomic testing by companies was conducted. Results of the review demonstrate a shift toward physician-approved ordering.

Keywords: direct-to-consumer testing; pharmacogenomics.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

    1. Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526(7573):343–350. - PMC - PubMed
    1. O’Donnell PH, Wadhwa N, Danahey K, et al. Pharmacogenomics-based point-of-care clinical decision support significantly alters drug prescribing. Clin Pharmacol Ther. 2017 Apr 11; Epub. - PMC - PubMed
    1. Filipski KK, Pacanowski MA, Ramamoorthy A, Feero WG, Freedman AN. Dosing recommendations for pharmacogenetic interactions related to drug metabolism. Pharmacogenet Genom. 2016;26(7):334–339. - PubMed
    1. Stanek EJ, Sanders CL, Taber KA, et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther. 2012;91(3):450–458. - PubMed
    1. Chua EW, Kennedy MA. Current state and future prospects of direct-to-consumer pharmacogenetics. Front Pharmacol. 2012;3:152. - PMC - PubMed

LinkOut - more resources